![Dick Sietses](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dick Sietses
Direktor/Vorstandsmitglied bei FABPulous BV
Ursprung des Netzwerks ersten Grades von Dick Sietses
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
FABPulous BV
![]() FABPulous BV Medical SpecialtiesHealth Technology FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands.
8
| Holding Company | Medical Specialties | 8 |
Livassured BV
![]() Livassured BV Electronic Equipment/InstrumentsElectronic Technology Livassured BV develops monitoring devices for epilepsy patients that identifies nocturnal seizures. The company was founded by Mark Bloemendaal and Asmund Tielens and is headquartered in Vught, the Netherlands.
6
| Holding Company | Electronic Equipment/Instruments | 6 |
Health Innovations BV
![]() Health Innovations BV Investment ManagersFinance Health Innovations BV is an independent private equity firm founded in 2011. The firm is headquartered in Utrecht, the Netherlands.
3
| Private Company | Investment Managers | 3 |
Residex BV
![]() Residex BV Investment ManagersFinance Residex BV is a private equity and venture capital fund manager based in Apeldoorn, Netherlands. Residex traces their history to 1987 when the firm was set up as Participatiemaatschappij BV in The Hague. The current firm was formally established in 1991. Residex is a subsidiary of Achmea Holding NV which provides insurance and financial services. The ultimate parent firm is Eureko BV, which offers insurance services as well as asset management and banking services. Since 1996, Residex focuses on investments in the healthcare sector and specializes in expansion capital, MBOs, MBIs and re-structuring transactions. They manage a number of venture funds with a healthcare/life sciences focus as well as those in biotechnology and the pharmaceutical industries.
2
| Subsidiary | Investment Managers | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dick Sietses
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
DIALOG SEMICONDUCTOR | Semiconductors | Corporate Officer/Principal | |
NV Limburgs Instituut voor Ontwikkeling en Financiering
![]() NV Limburgs Instituut voor Ontwikkeling en Financiering Investment ManagersFinance NV Limburgs Instituut voor Ontwikkeling en Financiering (LIOF) is a private equity & venture capital firm, a subsidiary of Government of the Netherlands founded in 1935. NV Limburgs Instituut voor Ontwikkeling en Financiering is headquartered in Maastricht, the Neterlands. | Investment Managers | Private Equity Investor | |
University of Twente | College/University | Graduate Degree | |
Dialog Semiconductor BV
![]() Dialog Semiconductor BV SemiconductorsElectronic Technology Dialog Semiconductor BV designs, develops, and manufactures semiconductor based system solutions. The company is headquartered in Hertogenbosch, the Netherlands. | Semiconductors | Chief Executive Officer | |
The Open University | College/University | Masters Business Admin | |
University of Hamburg | College/University | Graduate Degree | |
University of Utrecht | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
Holland Capital Management BV
![]() Holland Capital Management BV Investment ManagersFinance Holland Capital Management BV (Holland Capital) is an independent private equity & venture capital firm founded in 1981. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor | |
DSM Agro BV
![]() DSM Agro BV Chemicals: AgriculturalProcess Industries DSM Agro BV produces and sells nitrogen fertilizers and industrial products. It offers fertilizers like Nutramon 27 N + 4 MgO, Ammonium nitrate 33.5 N, Agnesamon 22 N + 7 MgO and Urean. The company is headquartered in Sittard, the Netherlands. | Chemicals: Agricultural | Chief Tech/Sci/R&D Officer | |
Brabantse Ontwikkelings Maatschappij Holding BV
![]() Brabantse Ontwikkelings Maatschappij Holding BV Investment ManagersFinance Brabantse Ontwikkelings Maatschappij Holding BV (BOM) is an industrial and economic development agency headquarterd in Tilburg in the southern Netherlands. Established in 1983, BOM is funded and financed by the Dutch State and the Province of Noord-Brabant. The firm offers a range of services designed to create, develop, maintain and improve the industrial structure of the region through four core activities: venture capital, foreign investment, new business and industrial parks. In particular BOM manages the Technostartersfonds, also known as the TechnoStars funds, which are regional venture capital investment vehicles based in Eindhoven. The investors are primarily institutions and high-net worth private individuals. | Investment Managers | Private Equity Investor | |
Observision BV
![]() Observision BV Miscellaneous Commercial ServicesCommercial Services Observision, the innovative market leader in security, presents a new generation of integrated security solutions, based on the company's own video and audio technology. With offices in the Netherlands and the United States, and in close cooperation with international systems integrators, they are able to solve highly complex security problems in existing and new (wireless) camera networks. Its customers operate in a wide range of sectors and include police forces, international airports, municipal governments for video surveillance, power stations and road, tunnel, bridge, high-voltage network and industrial complex operators. | Miscellaneous Commercial Services | Chief Executive Officer | |
Thuja Capital Management BV
![]() Thuja Capital Management BV Investment ManagersFinance Thuja Capital Management BV is a Venture Capital firm, a subsidiary of Thuja Capital Holding BV founded in 2006 by Harrold van Barlingen. Thuja Capital Management BV is headquartered in Utrecht. | Investment Managers | Private Equity Investor | |
Janssen Pharmaceutica NV
![]() Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BioMedbooster BV
![]() BioMedbooster BV Miscellaneous Commercial ServicesCommercial Services BioMedbooster BV provides valorization services. It supports businesses in translating their inventions or ideas into products ready for marketing. The company builds bridges between scientific research and industry, especially in life sciences and biomedical technologies. The firm offers evaluation of commercial potential of the invention, market analysis, managing the patenting process, business plan development, financial support for patent application in selected cases, business development financing, finding seed capital, monitoring contracts and payments, strong connections in scientific, industrial and financial communities, finding licensees and monitoring patent infringement. BioMedbooster was founded in 2005 and is headquartered in Maastricht, the Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ontwikkelingsmaatschappij Oost Nederland NV
![]() Ontwikkelingsmaatschappij Oost Nederland NV Investment ManagersFinance Ontwikkelingsmaatschappij Oost Nederland NV (Development Agency East Netherlands) is an Independent Private Equity/Venture Capital firm that focuses its activities on strengthening the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NV is headquartered in Apeldoorn. | Investment Managers | Private Equity Investor | |
InteRNA Technologies BV
![]() InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member | |
Astellas Pharma SAS
![]() Astellas Pharma SAS Medical DistributorsDistribution Services Astellas Pharma SAS wholesales pharmaceutical products. The company was founded in 2005 and is headquartered in Levallois-Perret, France. | Medical Distributors | Corporate Officer/Principal | |
Wageningen University | College/University | Doctorate Degree | |
DCPrime BV
![]() DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
NightBalance BV
![]() NightBalance BV Medical DistributorsDistribution Services NightBalance BV develops and markets sensor-devices for the treatment of sleep apnea. It offers sleep position trainer, a small and light aid which can be worn around the chest with an ergonomic band. The firm's a sleep position sensor which gradually and comfortably trains patients using vibrations to not sleep on their back. The company was founded by Eline van Beest and Thijs van Oorschot in 2009 and is headquartered in The Hague, the Netherlands. | Medical Distributors | Director/Board Member | |
Cristal Delivery BV
![]() Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Mellon Medical BV
![]() Mellon Medical BV Medical SpecialtiesHealth Technology Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
ViCentra BV
![]() ViCentra BV Electronic Equipment/InstrumentsElectronic Technology ViCentra BV engages in the development of medical devices. It focuses in creating devices for diabetes patients. The company was founded by Tim Oakes and Joseph John Cefai in 2013 and is headquartered in Utrecht, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
Brightlands Venture Partners BV
![]() Brightlands Venture Partners BV Investment ManagersFinance Brightlands Venture Partners is an independent regional venture capital firm headquartered in Brightlands, Netherlands. The firm was founded in 2004. | Investment Managers | Private Equity Investor | |
Nutrileads BV
![]() Nutrileads BV Food: Major DiversifiedConsumer Non-Durables Nutrileads BV develops food ingredi?nts with a specific nutritional value. It identifies promising lead ingredients, develops sustainable and commercially viable production processes and initiates scientific and clinical programs to test the health effects. The company was founded in 2012 by Erik Dam and Ruud Albers and is headquartered in Wageningen, the Netherlands. | Food: Major Diversified | Director/Board Member | |
Redmedtech Discovery Fund (Management)
![]() Redmedtech Discovery Fund (Management) Investment ManagersFinance Redmedtech Discovery Fund is an independent private equity firm with its headquarters in Apeldoorn, the Netherlands. It was founded in 2014. | Investment Managers | Private Equity Investor | |
FYEO Medical BV
![]() FYEO Medical BV Medical/Nursing ServicesHealth Services FYEO Medical BV is a company based in the Netherlands that specializes in providing the best solutions for vision correction through procedures such as laser eye surgery and lens implantation. The Dutch company's services offer the convenience of living without glasses or contact lenses. Founded in 2002, Rens Schoenmakers has been the CEO of the company since 2019. | Medical/Nursing Services | Chief Executive Officer | |
Alveron Pharma BV
![]() Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member | |
Angiogenesis Analytics BV
![]() Angiogenesis Analytics BV Miscellaneous Commercial ServicesCommercial Services Angiogenesis Analytics BV is a Dutch company that aims to improve the diagnosis of prostate cancer by using artificial intelligence technology and ultrasound imaging. The company is based in 's-Hertogenbosch, Netherlands and was founded in 2018 by Mark Bloemendaal, who has been the CEO since then. The company's product, PCaVision, is an ultrasound-based computer aided diagnosis for prostate cancer. The company provides resources in their archive, including documentation of the PCaVision journey from the beginning, awards and grants, and journal articles and theses covering the science behind PCaVision. | Miscellaneous Commercial Services | Chief Executive Officer | |
Sirius Medical Systems BV
![]() Sirius Medical Systems BV Medical SpecialtiesHealth Technology Sirius Medical BV engages in medical industry. The firm focuses on developing medical devices for oncological surgery. The company was founded by Hubert Martens and Bram Schermers and is headquartered in Eindhoven, the Netherlands. | Medical Specialties | Director/Board Member | |
BV HealthConnected
![]() BV HealthConnected Information Technology ServicesTechnology Services BV HealthConnected is a healthcare platform that aims to improve the quality of care by using ICT. The company is based in Alkmaar, Netherlands, and has a clear vision of how ICT can improve healthcare. The platform connects thousands of care providers and millions of patients, and it is designed for primary care, network care, and the entire region. The Dutch company values information security and has a flexible CISO. The company also has an e-learning application and share their success stories and knowledge on various topics through their publications. BV HealthConnected offers vacancies for those who want to contribute to society. Paul Witteman has been the CEO of the company since 2018. | Information Technology Services | Director/Board Member | |
Netherlands Foreign Investment Agency (Netherlands)
![]() Netherlands Foreign Investment Agency (Netherlands) Investment ManagersFinance Part of Netherlands Foreign Investment Agency, the Dutch company provides investment advisory services. | Investment Managers | Director/Board Member | |
Pan Cancer T
![]() Pan Cancer T BiotechnologyHealth Technology Pan Cancer T is a company based in Rotterdam, Netherlands that was founded in 2020 by Reno Debets, Dora Hammerl. The Dutch company focuses on advancing next generation TCR T cell therapies for hard-to-treat solid tumors. The company's approach includes exploiting unique targets for T cells that are exclusively and robustly expressed by multiple solid cancers and developing technologies that enhance the durability of the T cells. The company has ongoing R & D programs to develop safe and effective adoptive T cell therapies for patients with triple negative breast cancer as well as cancers of the bladder, ovarium, colorectum, prostate, skin, esophagus, lung, or brain. Rachel Abbott has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
EsoBiotec SA
![]() EsoBiotec SA Miscellaneous Commercial ServicesCommercial Services EsoBiotec SA is a Belgian company that provides research and development on natural sciences and engineering. The company is based in Charleroi, Belgium. The company was founded in 2020 by Jean-Pierre Latere. Jean-Pierre Latere has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
CimCure BV
![]() CimCure BV Miscellaneous Commercial ServicesCommercial Services CimCure BV is a Dutch new generation company founded in 2015 as a spin-off of the VU University Medical Center. CimCure is based in Amsterdam, Netherlands. The company focuses on the design and development of a novel class of active cancer vaccines that target the tumor blood vessels common to most solid tumors. CimCure has discovered and patented multiple highly specific targets and a novel conjugate vaccine technology that can induce polyclonal antibody responses to targets specific to the tumor vasculature. The company aims to combine the proven efficacy of tumor angiogenesis inhibition with the advantages that a vaccine may provide. The company was founded in 2015 by Arjan W. Griffioen, and Diederik Engbersen has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chief Executive Officer | |
FundaMental Pharma GmbH
![]() FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology FundaMental Pharma GmbH is a neuroscience company based in Heidelberg, Germany. The German company develops first-in-class small inhibitors for the treatment of a range of neurodegenerative diseases. The company's scientists have discovered an entirely new class of drugs that safely counteract glutamate excitotoxicity, a common cause of neurodegeneration. The company's current focus is on amyotrophic lateral sclerosis (ALS) and Huntington's disease, but the applicability of these molecules extends to a range of neurodegenerative disorders such as dementia and aging-related memory loss. FundaMental Pharma was founded in 2016 by Thomas Schulze, Hilmar Bading, and Daniela Mauceri, and Thomas Schulze has been the CEO since 2016. | Pharmaceuticals: Major | Director/Board Member | |
Xilloc Medical Int BV
![]() Xilloc Medical Int BV Medical SpecialtiesHealth Technology Xilloc Medical Int BV is a Dutch company that manufactures medical instruments, implants, and anatomical models. The company is based in Sittard-Geleen, the Netherlands, and has subsidiaries in the Netherlands. The company was founded in 2003 by Maikel Beerens, and the CEO is Milko Wijckmans. | Medical Specialties | Director/Board Member |
Statistik
International
Niederlande | 36 |
Vereinigtes Königreich | 3 |
Deutschland | 3 |
Belgien | 3 |
Frankreich | 2 |
Sektoral
Finance | 11 |
Health Technology | 11 |
Commercial Services | 9 |
Consumer Services | 6 |
Electronic Technology | 4 |
Operativ
Director/Board Member | 24 |
Private Equity Investor | 12 |
Chief Executive Officer | 10 |
Corporate Officer/Principal | 5 |
Graduate Degree | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Dick Sietses
- Unternehmensverbindungen